Hemostatic Disorders on Intensive Care Patients.
Hemostatic Disorders Impact on Intensive Care Patients.
1 other identifier
observational
100
0 countries
N/A
Brief Summary
- 1.To assess the incidence of hemostatic disorders among ICU patients.
- 2.To establish a relationship between supportive treatment and survival in patients with coagulopathy in ICU.
- 3.To provide solutions that can help in reduction of the incidence of hemostatic disorders in ICU patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2019
CompletedFirst Posted
Study publicly available on registry
November 27, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedNovember 27, 2019
November 1, 2019
8 months
September 24, 2019
November 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Describe the Pattern of Homeostasis Disorders occur in Critical Care Unit in Assiut University
Study the causes of either bleeding or thrombotic events in Critical care unit. Describe the pattern of the disease regarding age, sex and predisposing factors.
Baseline
Secondary Outcomes (1)
Correlate Supportive and Definitive Treatment and Outcomes of Patients with Homeostasis Disorder in ICU.
Baseline
Eligibility Criteria
All cases who will be admitted at the intensive care units at Assiut university Hospital through 1 year duration .
You may qualify if:
- Intensive care unit patients,aged more than 18 years .
- Any Acquired bleeding disorders (platelet disorders; thrombocytopenia, acquired thrombocythemia and thrombocytosis, acquired coagulation defect, Thrombophilia ) Diagnosed in Critical care unit in Assiut university in one year time frame
You may not qualify if:
- Patient less than 18 years.
- Patients with Inherited platelet defects ( Amegakaryoctye aplasia and Bernard Soulir syndrome)
- Patients with Inherited coagulation defects (e.g.hemophilia , Von Willebrand disease and any inherited coagulation defect.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Retter A, Barrett NA. The management of abnormal haemostasis in the ICU. Anaesthesia. 2015 Jan;70 Suppl 1:121-7, e40-1. doi: 10.1111/anae.12908.
PMID: 25440406BACKGROUNDHunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014 Feb 27;370(9):847-59. doi: 10.1056/NEJMra1208626. No abstract available.
PMID: 24571757BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Doctor
Study Record Dates
First Submitted
September 24, 2019
First Posted
November 27, 2019
Study Start
January 1, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
November 27, 2019
Record last verified: 2019-11